Alamar Biosciences Prices Initial Public Offering at Deep Discount to Market, Raising $191.25M
ALMR is trading near its 52-week low of $21.5 (3.5% above the low).
Summary
Alamar Biosciences priced its initial public offering of 11,250,000 shares at $17.00 each, raising $191.25 million in gross proceeds. The pricing is significantly below the current market price and 52-week low, leading to substantial dilution for existing shareholders.
Key Events · Financing and Capital Events · ALMR
-
Initial Public Offering Priced
Alamar Biosciences priced its initial public offering of 11,250,000 shares of common stock at $17.00 per share, generating gross proceeds of $191.25 million.
-
Significant Capital Raise
The company expects to receive approximately $177.86 million in net proceeds after deducting underwriting discounts and estimated offering expenses, which will be used for general corporate purposes, including working capital, operating expenses, and capital expenditures.
-
Substantial Dilution
The offering will result in approximately 16.9% dilution, with 11,250,000 new shares being issued out of a total of 66,521,425 shares outstanding immediately after the offering.
-
Pricing Below Market and 52-Week Low
The IPO price of $17.00 per share is significantly below the current stock price of $22.26 and the company's 52-week low of $21.50, indicating a deep discount to market valuation.
Analysis · ALMR · Industrial Applications And Services
Alamar Biosciences has priced its initial public offering (IPO) of 11,250,000 shares at $17.00 per share, raising approximately $177.86 million in net proceeds. This pricing represents a significant discount compared to the current stock price of $22.26 and is even below the company's 52-week low of $21.50, indicating weak investor demand or a pressing need for capital. The offering will result in substantial dilution for existing shareholders, with the new shares representing approximately 16.9% of the total outstanding shares post-IPO. While the capital infusion is critical for the company, which has a history of net losses and negative cash flows, the deep discount pricing signals a challenging market reception for its public debut.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALMR was trading at $22.26 on NASDAQ in the Industrial Applications And Services sector. The 52-week trading range was $21.50 to $24.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.